The Royal Pharmaceutical Society (RPS) has announced the results of the 2024 elections for its three national Pharmacy Boards.
For the English Pharmacy Board, the newly elected members include Claire Anderson, Martin Astbury, Steve Churton, Ciara Duffy, Sue Ladds, Mike Maguire, Tase Oputu
and Ankish Patel.
Matthew Prior has been elected for a period of one year to fill the casual vacancy on the Board.
Seven candidates have been elected unopposed to the RPS Scottish Pharmacy Board. They include: Jonathan Burton, Lucy Dixon, Laura Fulton, Catriona Sinclair, Amina
Slimani-Fersia, Richard Strang and Audrey Thompson. Only seven nominations were received for the eight substantive vacancies on the board.
Helen Davies has been elected to the RPS Welsh Pharmacy Board to represent the Primary Care sector. Meanwhile, Rafia Jamil and Geraldine McCaffrey have been
elected unopposed to fill the two vacancies in the Hospital sector.
The Royal Pharmaceutical Society (RPS) has published a consultation to review the 'Professional standards for the reporting, learning, sharing, taking action
and review of incidents error reporting' in collaboration with Association of Pharmacy Technicians UK and Pharmacy Forum of Northern Ireland.
The consultation is open from 21 April 2023 until 2 June 2023 and are due to be published in early 2024.
All three professional leadership bodies are calling for contributions from anyone using the standards to ensure they are clear, current, relevant and fit for
purpose.
"The review affects all pharmacists, pharmacy technicians, trainees and members of the pharmacy team working in all sectors across the UK," RPS said.
"The standards may also be of interest to the public, people who use pharmacy and healthcare services, healthcare and professionals working with pharmacy teams.
Hobbs, who joined the company in 2019, navigated it through the challenges of the COVID-19 pandemic, and successfully oversaw the acquisition and integration
of Lexon in 2023. He will retire from the company at the end of September 2024.
"After five years with the company, I am retiring at the end of September to spend time with my wife who was diagnosed with motor neurone disease last year," Hobbs
said.
"I wish to extend my personal thanks to our owners, the Bestway Group, for their kindness and understanding of our situation.
"It has been a privilege to lead the Well Pharmacy, now Bestway Healthcare organisation. The business is resilient for today and fit to prosper in the long term.
When I leave it will be with gratitude and admiration for the 7,500+ people in Bestway Healthcare who are committed to improving the lives of our patients and
customers, thank you all."
The Pharmacists' Defence Association (PDA) has emerged as a key player in international humanitarian efforts, delivering millions of pounds worth of medical
aid to disaster-hit regions.
This marks a significant evolution for the PDA, which has embraced a leadership role in global relief initiatives.
The PDA, a member of the Employed Pharmacists of Europe (EPhEU), responded to an urgent appeal from its Ukrainian members following the extensive damage to
Ukraine's healthcare infrastructure during the military invasion.
As the elected Secretary General of EPhEU, PDA Chairman Mark Koziol orchestrated a campaign encouraging public donations through 'Medicines to Ukraine' posters
displayed in pharmacies across Europe.
The campaign successfully raised over £4.5 million, which was used to procure and deliver essential medicines directly to Ukrainian Ministry of Health pharmacists.
The Professional Records Standards Body (PRSB), which develops information standards for health and social care records, has appointed Professor Reecha
Sofat as the new Chair.
She will assume the role at the end of October 2024, succeeding Professor Maureen Baker CBE, who will step down after seven years as Chair of the PRSB.
A Clinical Pharmacologist, Professor Sofat has held many leadership roles across the NHS, academia and scientific societies.
Professor Sofat is Breckenridge Chair of Clinical Pharmacology at the University of Liverpool. She practices general internal medicine and is also an Associate
Director at the British Heart Foundation (BHF) Data Science Centre (DSC) which is led by Health Data Research UK (HDRUK).
With a passion for data science and extensive clinical and research insights, Professor Sofat is focused on embedding research into routine health and social care.
She said: "I am passionate about using the rich health data that is already collected across NHS and social care to better understand the causes and consequences
of disease and improve health outcomes.
Walgreens Boots Alliance (WBA) has officially announced that Sebastian James, the Managing Director of Boots, will be stepping down from his role to pursue
a new opportunity in the healthcare sector.
James has given notice to leave the company and will remain with Boots until November. The UK pharmacy giant has already begun the search for a new Managing Director.
James is set to take on the role of CEO at Veonet, a leading European chain of ophthalmology clinics.
During his tenure as Managing Director since 2018, James played a pivotal role in transforming Boots into the UK's leading health and beauty retailer.
He oversaw significant growth and innovation, achieving thirteen consecutive quarters of retail market share growth. Most recently, the company announced strong
Q3 results in June with growth across all categories.